Recombinant Human OTOR Protein，His

OTOR (Osteoactivin, also known as OC/OTOR) is a protein that has garnered significant attention in recent years due to its involvement in various physiological processes, including bone metabolism, immune responses, and tissue repair. Initial studies indicated that OTOR is expressed in osteoblasts and osteoclasts, leading researchers to explore its role in bone homeostasis and potential implications for osteoporosis and other bone-related disorders. Furthermore, OTOR has been implicated in inflammatory processes and may play a critical role in modulating immune responses, making it a potential target for therapeutic interventions in autoimmune diseases and inflammation-related conditions. Advances in molecular biology techniques have enabled scientists to investigate the mechanisms of OTOR more comprehensively, revealing its complex interactions with signaling pathways involved in cell proliferation and differentiation. Given the increasing prevalence of diseases associated with bone and immune systems, the research on OTOR is crucial for developing novel therapeutic strategies. Understanding its structure, function, and regulatory mechanisms could provide valuable insights into disease pathology and lead to the identification of new biomarkers for diagnosis and treatment efficacy. Overall, OTOR represents a promising area of research, bridging molecular biology with clinical applications, and holds the potential to contribute significantly to our understanding of bone health and immunological functions.